Business, energy, technology, markets and global industry news from Business News Today

Vanderbilt University Medical Center

PharmaDeviceNews Vanderbilt University Medical Center
Infographic showing Laplace Interventional’s TRIUMPH pivotal trial, highlighting treatment of the first three patients, the FDA-authorised randomised study design, and plans to enrol about 400 patients for its investigational tricuspid valve.
Medical Devices & Diagnostics

Laplace Interventional is taking on an approved tricuspid valve with TRIUMPH, but can its new implant deliver better outcomes?

Laplace Interventional has treated the first three patients in its FDA-authorised TRIUMPH pivotal trial, moving its investigational tricuspid valve into a randomised comparison with commercial replacement technology. With approximately 400 patients planned for the main study, the company must demonstrate meaningful safety and effectiveness in an increasingly competitive structural heart market.

Read More
Representative image: Ophthalmology slit-lamp examination reflecting the unmet treatment need in neuropathic corneal pain as OKYO Pharma advances urcosimod toward the Phase 3 NEPTUNE trial.
Medical Devices & Diagnostics

Can Stuart Therapeutics’ ST-100 heal damaged corneas? A new FDA filing opens a critical test

Stuart Therapeutics files an FDA amendment for ST-100 corneal wound trials, with collagen repair evidence and 2027 milestones in focus.

Read More
Microbiome-based colorectal cancer screening research advances as the National Cancer Institute funds Intus Bio to develop an early detection test for early-onset colorectal cancer and precancerous colorectal lesions. Representative image.
Medical Devices & Diagnostics

Intus Biosciences gets $2.7m NCI award for microbiome-based early-onset colorectal cancer test

NCI awards Intus Bio $2.7 million to develop a microbiome-based test for early-onset colorectal cancer and precancerous lesions.

Read More